Font Size: a A A
Keyword [Extranodal natural killer/T cell lymphoma]
Result: 1 - 19 | Page: 1 of 1
1. Research On The Treatment Modality, Radiotherapy Planning And Prognostic Factors Of Early Stage Extranodal Natural Killer/T-cell Lymphoma
2. Research On The Relationship Between EB Virus And Curative Effect In Extranodal Natural Killer/T-Cell Lymphoma
3. Expression And Clinical Significance Of C-Myc And Ki-67 In Extranodal Natural Killer/T-cell Lymphoma,Nasal Type
4. Prognostic Relevance Of Absolute Lymphocyte Count And Lymphocyte Count In Patients With Extranodal Natural Killer/T-cell Lymphoma
5. Research On Therapy And Prognosis In Extranodal Natural Killer/T Cell Lymphoma And Burkitt Lymphoma
6. The Clinical Features And Prognosis Of EBER Negative Extranodal Natural Killer/T-Cell Lymphoma
7. The Clinical Features And Survival Prognosis Analysis Of Non-upperaerodigestive Tract Extranodal Natural Killer/T-cell Lymphoma
8. The Correlation Analysis Of The Reactive Splenomegaly And The Curative Effect And Prognosis In The Extranodal NK/T Cell Lymphoma
9. Comparison Of Efficacy And Analysis Of Prognosis Of Radiotherapy Alone,PGEMOX Regimen Sequential Radiotherapy,and PGEMOX Regimen Sandwich Radiotherapy Treatment For Early Stage Extranodal Natural Killer/T Cell Lymphoma
10. Treatment And Prognosis For Diffuse Large B-cell Lymphoma And NK/T-cell Lymphoma
11. IL-13 Promotes Cell Proliferation In Extranodal Natural Killer/T Cell Lymphoma
12. Aquaporin 3 Facilitates Chemoresistance In Extranodal Natural Killer/T Cell Lymphoma To Gemcitabine
13. The Clinical Study Of Concurrent Chemoradiotherapy For Extranodal Natural Killer/t-cell Lymphoma Nasal Type In Localized Stages
14. The Expression And Prognostic Value Of PD-1,TIM-3,LAG-3 And BTLA In Extranodal NK/T Cell Lymphoma
15. A Polymorphic Predictive Model For Extranodal Nasal NK/T-cell Lymphoma
16. Analysis Of Prognostic Value Of Four18F-FDG PET/CT Evaluation Methods In Extranodal Natural Killer/T-cell Lymphoma
17. Clinical Analysis Of PD-1 Receptor Inhibitor Combined With P-Gemox-Dex Regimen In The Primary Treatment Of Phase ?/? Extranodal Natural Killer/T Cell Lymphoma
18. 18F-FDG PET/CT Based Radiomics In Predicting The Prognosis For Patients With Natural Killer/T Cell Lymphoma
19. Clinical Characteristics And Survival Of Extranodal Natural Killer/T-Cell Lymphoma
  <<First  <Prev  Next>  Last>>  Jump to